insights_auto
Why is ORX down 3,08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,85 SEK
arrow_downward
-3,08%(-0,027) 1D
16 ნოე, 17:29:42 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 მლნ.
Avg. vol.
777,72 ათ.
Volume
415,89 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 მლნ.
Avg. vol.
777,72 ათ.
Volume
415,89 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Gap-Down Movers in Nov. 16, 2026 Session
MarketWatch
·
54 წუთის წინ
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
upi
·
2 საათის წინ
KB Kookmin Bank debuts S&P 500-linked dollar deposit product
Traders Union
·
1 საათის წინ
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com